nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurazepam—CYP2A6—Prednisolone—ankylosing spondylitis	0.175	0.196	CbGbCtD
Flurazepam—CYP2A6—Dexamethasone—ankylosing spondylitis	0.103	0.116	CbGbCtD
Flurazepam—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0909	0.102	CbGbCtD
Flurazepam—CYP2E1—Dexamethasone—ankylosing spondylitis	0.068	0.0763	CbGbCtD
Flurazepam—ABCB1—Betamethasone—ankylosing spondylitis	0.0591	0.0663	CbGbCtD
Flurazepam—ABCB1—Prednisolone—ankylosing spondylitis	0.0583	0.0655	CbGbCtD
Flurazepam—ABCB1—Prednisone—ankylosing spondylitis	0.0551	0.0618	CbGbCtD
Flurazepam—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0545	0.0611	CbGbCtD
Flurazepam—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0413	0.0463	CbGbCtD
Flurazepam—CYP3A4—Betamethasone—ankylosing spondylitis	0.0354	0.0397	CbGbCtD
Flurazepam—CYP3A4—Prednisolone—ankylosing spondylitis	0.035	0.0392	CbGbCtD
Flurazepam—ABCB1—Dexamethasone—ankylosing spondylitis	0.0344	0.0386	CbGbCtD
Flurazepam—CYP3A4—Prednisone—ankylosing spondylitis	0.033	0.037	CbGbCtD
Flurazepam—ABCB1—Methotrexate—ankylosing spondylitis	0.0276	0.031	CbGbCtD
Flurazepam—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0206	0.0231	CbGbCtD
Flurazepam—Chloroquine—TNF—ankylosing spondylitis	0.00243	1	CrCbGaD
Flurazepam—Withdrawal syndrome—Prednisone—ankylosing spondylitis	0.00215	0.0299	CcSEcCtD
Flurazepam—GABRQ—Orphan transporters—ANO6—ankylosing spondylitis	0.00169	0.0493	CbGpPWpGaD
Flurazepam—GABRG3—Orphan transporters—ANO6—ankylosing spondylitis	0.00139	0.0406	CbGpPWpGaD
Flurazepam—GABRB1—Orphan transporters—ANO6—ankylosing spondylitis	0.00137	0.04	CbGpPWpGaD
Flurazepam—GABRA6—Orphan transporters—ANO6—ankylosing spondylitis	0.0013	0.0379	CbGpPWpGaD
Flurazepam—GABRA4—Orphan transporters—ANO6—ankylosing spondylitis	0.00128	0.0374	CbGpPWpGaD
Flurazepam—GABRR1—Ion channel transport—ANO6—ankylosing spondylitis	0.00124	0.0363	CbGpPWpGaD
Flurazepam—GABRQ—Ion channel transport—ANO6—ankylosing spondylitis	0.00119	0.0346	CbGpPWpGaD
Flurazepam—GABRR2—Ion channel transport—ANO6—ankylosing spondylitis	0.00119	0.0346	CbGpPWpGaD
Flurazepam—GABRB2—Orphan transporters—ANO6—ankylosing spondylitis	0.00117	0.0342	CbGpPWpGaD
Flurazepam—GABRA5—Orphan transporters—ANO6—ankylosing spondylitis	0.00114	0.0332	CbGpPWpGaD
Flurazepam—GABRA3—Orphan transporters—ANO6—ankylosing spondylitis	0.00112	0.0326	CbGpPWpGaD
Flurazepam—GABRA2—Orphan transporters—ANO6—ankylosing spondylitis	0.0011	0.0321	CbGpPWpGaD
Flurazepam—GABRB3—Orphan transporters—ANO6—ankylosing spondylitis	0.00109	0.0318	CbGpPWpGaD
Flurazepam—GABRG2—Orphan transporters—ANO6—ankylosing spondylitis	0.00107	0.0313	CbGpPWpGaD
Flurazepam—Euphoric mood—Prednisolone—ankylosing spondylitis	0.00106	0.0148	CcSEcCtD
Flurazepam—Euphoric mood—Triamcinolone—ankylosing spondylitis	0.000979	0.0136	CcSEcCtD
Flurazepam—GABRG3—Ion channel transport—ANO6—ankylosing spondylitis	0.000978	0.0285	CbGpPWpGaD
Flurazepam—Euphoric mood—Methylprednisolone—ankylosing spondylitis	0.000977	0.0136	CcSEcCtD
Flurazepam—GABRB1—Ion channel transport—ANO6—ankylosing spondylitis	0.000963	0.0281	CbGpPWpGaD
Flurazepam—Blood alkaline phosphatase increased—Methylprednisolone—ankylosing spondylitis	0.000949	0.0132	CcSEcCtD
Flurazepam—GABRA1—Orphan transporters—ANO6—ankylosing spondylitis	0.000938	0.0273	CbGpPWpGaD
Flurazepam—Anaphylactoid reaction—Prednisolone—ankylosing spondylitis	0.000929	0.0129	CcSEcCtD
Flurazepam—GABRA6—Ion channel transport—ANO6—ankylosing spondylitis	0.000912	0.0266	CbGpPWpGaD
Flurazepam—GABRA4—Ion channel transport—ANO6—ankylosing spondylitis	0.0009	0.0262	CbGpPWpGaD
Flurazepam—Euphoric mood—Dexamethasone—ankylosing spondylitis	0.000888	0.0123	CcSEcCtD
Flurazepam—Euphoric mood—Betamethasone—ankylosing spondylitis	0.000888	0.0123	CcSEcCtD
Flurazepam—Anaphylactoid reaction—Triamcinolone—ankylosing spondylitis	0.000854	0.0119	CcSEcCtD
Flurazepam—Anaphylactoid reaction—Methylprednisolone—ankylosing spondylitis	0.000852	0.0118	CcSEcCtD
Flurazepam—GABRB2—Ion channel transport—ANO6—ankylosing spondylitis	0.000823	0.024	CbGpPWpGaD
Flurazepam—GABRA5—Ion channel transport—ANO6—ankylosing spondylitis	0.0008	0.0233	CbGpPWpGaD
Flurazepam—Dysarthria—Methotrexate—ankylosing spondylitis	0.000795	0.0111	CcSEcCtD
Flurazepam—Irritability—Methylprednisolone—ankylosing spondylitis	0.000787	0.0109	CcSEcCtD
Flurazepam—GABRA3—Ion channel transport—ANO6—ankylosing spondylitis	0.000785	0.0229	CbGpPWpGaD
Flurazepam—Hyperkinesia—Prednisone—ankylosing spondylitis	0.000785	0.0109	CcSEcCtD
Flurazepam—Anaphylactoid reaction—Dexamethasone—ankylosing spondylitis	0.000775	0.0108	CcSEcCtD
Flurazepam—Anaphylactoid reaction—Betamethasone—ankylosing spondylitis	0.000775	0.0108	CcSEcCtD
Flurazepam—Euphoric mood—Prednisone—ankylosing spondylitis	0.000773	0.0107	CcSEcCtD
Flurazepam—GABRA2—Ion channel transport—ANO6—ankylosing spondylitis	0.000772	0.0225	CbGpPWpGaD
Flurazepam—GABRB3—Ion channel transport—ANO6—ankylosing spondylitis	0.000767	0.0223	CbGpPWpGaD
Flurazepam—Lethargy—Dexamethasone—ankylosing spondylitis	0.000766	0.0106	CcSEcCtD
Flurazepam—Lethargy—Betamethasone—ankylosing spondylitis	0.000766	0.0106	CcSEcCtD
Flurazepam—GABRG2—Ion channel transport—ANO6—ankylosing spondylitis	0.000753	0.0219	CbGpPWpGaD
Flurazepam—Irritability—Betamethasone—ankylosing spondylitis	0.000716	0.00995	CcSEcCtD
Flurazepam—Irritability—Dexamethasone—ankylosing spondylitis	0.000716	0.00995	CcSEcCtD
Flurazepam—Coma—Methotrexate—ankylosing spondylitis	0.000687	0.00955	CcSEcCtD
Flurazepam—Lethargy—Prednisone—ankylosing spondylitis	0.000667	0.00926	CcSEcCtD
Flurazepam—GABRA1—Ion channel transport—ANO6—ankylosing spondylitis	0.000658	0.0192	CbGpPWpGaD
Flurazepam—Irritability—Prednisone—ankylosing spondylitis	0.000624	0.00867	CcSEcCtD
Flurazepam—Sweating—Methylprednisolone—ankylosing spondylitis	0.00061	0.00847	CcSEcCtD
Flurazepam—Hallucination—Methylprednisolone—ankylosing spondylitis	0.000568	0.00789	CcSEcCtD
Flurazepam—Anaphylactoid reaction—Methotrexate—ankylosing spondylitis	0.000564	0.00784	CcSEcCtD
Flurazepam—Lethargy—Methotrexate—ankylosing spondylitis	0.000557	0.00774	CcSEcCtD
Flurazepam—Irritability—Methotrexate—ankylosing spondylitis	0.000521	0.00724	CcSEcCtD
Flurazepam—Hallucination—Dexamethasone—ankylosing spondylitis	0.000516	0.00718	CcSEcCtD
Flurazepam—Hallucination—Betamethasone—ankylosing spondylitis	0.000516	0.00718	CcSEcCtD
Flurazepam—Ataxia—Methotrexate—ankylosing spondylitis	0.000513	0.00713	CcSEcCtD
Flurazepam—Vision blurred—Prednisolone—ankylosing spondylitis	0.00051	0.00709	CcSEcCtD
Flurazepam—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.000488	0.00678	CcSEcCtD
Flurazepam—Syncope—Prednisolone—ankylosing spondylitis	0.000486	0.00675	CcSEcCtD
Flurazepam—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.000476	0.00661	CcSEcCtD
Flurazepam—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.000452	0.00629	CcSEcCtD
Flurazepam—Hallucination—Prednisone—ankylosing spondylitis	0.00045	0.00625	CcSEcCtD
Flurazepam—Syncope—Triamcinolone—ankylosing spondylitis	0.000447	0.0062	CcSEcCtD
Flurazepam—Syncope—Methylprednisolone—ankylosing spondylitis	0.000446	0.00619	CcSEcCtD
Flurazepam—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000442	0.00614	CcSEcCtD
Flurazepam—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000438	0.00608	CcSEcCtD
Flurazepam—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000437	0.00607	CcSEcCtD
Flurazepam—Shock—Prednisolone—ankylosing spondylitis	0.000435	0.00604	CcSEcCtD
Flurazepam—GABRR1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000433	0.0126	CbGpPWpGaD
Flurazepam—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000427	0.00594	CcSEcCtD
Flurazepam—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000423	0.00588	CcSEcCtD
Flurazepam—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000422	0.00586	CcSEcCtD
Flurazepam—Drowsiness—Methotrexate—ankylosing spondylitis	0.000421	0.00585	CcSEcCtD
Flurazepam—Flushing—Prednisone—ankylosing spondylitis	0.000419	0.00583	CcSEcCtD
Flurazepam—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000415	0.00576	CcSEcCtD
Flurazepam—GABRR2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000413	0.012	CbGpPWpGaD
Flurazepam—GABRQ—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000413	0.012	CbGpPWpGaD
Flurazepam—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000409	0.00568	CcSEcCtD
Flurazepam—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000406	0.00565	CcSEcCtD
Flurazepam—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000405	0.00563	CcSEcCtD
Flurazepam—Syncope—Dexamethasone—ankylosing spondylitis	0.000405	0.00563	CcSEcCtD
Flurazepam—Syncope—Betamethasone—ankylosing spondylitis	0.000405	0.00563	CcSEcCtD
Flurazepam—Sweating—Methotrexate—ankylosing spondylitis	0.000403	0.00561	CcSEcCtD
Flurazepam—Shock—Triamcinolone—ankylosing spondylitis	0.0004	0.00556	CcSEcCtD
Flurazepam—Shock—Methylprednisolone—ankylosing spondylitis	0.000399	0.00554	CcSEcCtD
Flurazepam—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000397	0.00552	CcSEcCtD
Flurazepam—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000397	0.00552	CcSEcCtD
Flurazepam—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000393	0.00546	CcSEcCtD
Flurazepam—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000393	0.00546	CcSEcCtD
Flurazepam—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000392	0.00545	CcSEcCtD
Flurazepam—Anxiety—Dexamethasone—ankylosing spondylitis	0.000383	0.00533	CcSEcCtD
Flurazepam—Anxiety—Betamethasone—ankylosing spondylitis	0.000383	0.00533	CcSEcCtD
Flurazepam—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000379	0.00526	CcSEcCtD
Flurazepam—Vision blurred—Prednisone—ankylosing spondylitis	0.000371	0.00515	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00037	0.00514	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000369	0.00513	CcSEcCtD
Flurazepam—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000369	0.00512	CcSEcCtD
Flurazepam—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000369	0.00512	CcSEcCtD
Flurazepam—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000364	0.00506	CcSEcCtD
Flurazepam—Shock—Betamethasone—ankylosing spondylitis	0.000363	0.00504	CcSEcCtD
Flurazepam—Shock—Dexamethasone—ankylosing spondylitis	0.000363	0.00504	CcSEcCtD
Flurazepam—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000362	0.00503	CcSEcCtD
Flurazepam—Agitation—Prednisone—ankylosing spondylitis	0.000362	0.00502	CcSEcCtD
Flurazepam—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000358	0.00497	CcSEcCtD
Flurazepam—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000357	0.00496	CcSEcCtD
Flurazepam—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000356	0.00495	CcSEcCtD
Flurazepam—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000356	0.00495	CcSEcCtD
Flurazepam—Syncope—Prednisone—ankylosing spondylitis	0.000353	0.0049	CcSEcCtD
Flurazepam—Anorexia—Dexamethasone—ankylosing spondylitis	0.000351	0.00488	CcSEcCtD
Flurazepam—Anorexia—Betamethasone—ankylosing spondylitis	0.000351	0.00488	CcSEcCtD
Flurazepam—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000346	0.00481	CcSEcCtD
Flurazepam—Hypotension—Betamethasone—ankylosing spondylitis	0.000345	0.00479	CcSEcCtD
Flurazepam—Hypotension—Dexamethasone—ankylosing spondylitis	0.000345	0.00479	CcSEcCtD
Flurazepam—GABRG3—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00034	0.00992	CbGpPWpGaD
Flurazepam—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000336	0.00467	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000336	0.00467	CcSEcCtD
Flurazepam—GABRB1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000335	0.00977	CbGpPWpGaD
Flurazepam—Arthralgia—Prednisone—ankylosing spondylitis	0.000335	0.00465	CcSEcCtD
Flurazepam—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000335	0.00465	CcSEcCtD
Flurazepam—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000334	0.00464	CcSEcCtD
Flurazepam—Anxiety—Prednisone—ankylosing spondylitis	0.000334	0.00464	CcSEcCtD
Flurazepam—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000332	0.00461	CcSEcCtD
Flurazepam—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000325	0.00451	CcSEcCtD
Flurazepam—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000325	0.00451	CcSEcCtD
Flurazepam—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000322	0.00447	CcSEcCtD
Flurazepam—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000321	0.00446	CcSEcCtD
Flurazepam—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000321	0.00445	CcSEcCtD
Flurazepam—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000321	0.00445	CcSEcCtD
Flurazepam—GABRA6—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000317	0.00924	CbGpPWpGaD
Flurazepam—Shock—Prednisone—ankylosing spondylitis	0.000316	0.00439	CcSEcCtD
Flurazepam—GABRA4—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000313	0.00913	CbGpPWpGaD
Flurazepam—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00031	0.00431	CcSEcCtD
Flurazepam—Vision blurred—Methotrexate—ankylosing spondylitis	0.00031	0.00431	CcSEcCtD
Flurazepam—Anorexia—Prednisone—ankylosing spondylitis	0.000306	0.00425	CcSEcCtD
Flurazepam—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000304	0.00422	CcSEcCtD
Flurazepam—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000304	0.00422	CcSEcCtD
Flurazepam—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000302	0.00419	CcSEcCtD
Flurazepam—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000302	0.00419	CcSEcCtD
Flurazepam—Leukopenia—Methotrexate—ankylosing spondylitis	0.000294	0.00409	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000293	0.00407	CcSEcCtD
Flurazepam—Dizziness—Prednisolone—ankylosing spondylitis	0.000292	0.00406	CcSEcCtD
Flurazepam—Asthenia—Triamcinolone—ankylosing spondylitis	0.000292	0.00405	CcSEcCtD
Flurazepam—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000291	0.00404	CcSEcCtD
Flurazepam—Pruritus—Triamcinolone—ankylosing spondylitis	0.000288	0.004	CcSEcCtD
Flurazepam—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000287	0.00399	CcSEcCtD
Flurazepam—GABRB2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000287	0.00835	CbGpPWpGaD
Flurazepam—Dyspepsia—Prednisone—ankylosing spondylitis	0.000283	0.00393	CcSEcCtD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—RUNX3—ankylosing spondylitis	0.000282	0.00821	CbGpPWpGaD
Flurazepam—Chest pain—Methotrexate—ankylosing spondylitis	0.00028	0.00389	CcSEcCtD
Flurazepam—Arthralgia—Methotrexate—ankylosing spondylitis	0.00028	0.00389	CcSEcCtD
Flurazepam—Decreased appetite—Prednisone—ankylosing spondylitis	0.000279	0.00388	CcSEcCtD
Flurazepam—Rash—Prednisolone—ankylosing spondylitis	0.000279	0.00387	CcSEcCtD
Flurazepam—Dermatitis—Prednisolone—ankylosing spondylitis	0.000278	0.00387	CcSEcCtD
Flurazepam—GABRA5—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000278	0.00811	CbGpPWpGaD
Flurazepam—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000277	0.00385	CcSEcCtD
Flurazepam—Headache—Prednisolone—ankylosing spondylitis	0.000277	0.00385	CcSEcCtD
Flurazepam—Constipation—Prednisone—ankylosing spondylitis	0.000275	0.00382	CcSEcCtD
Flurazepam—GABRA3—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000273	0.00796	CbGpPWpGaD
Flurazepam—Confusional state—Methotrexate—ankylosing spondylitis	0.000271	0.00376	CcSEcCtD
Flurazepam—Dizziness—Triamcinolone—ankylosing spondylitis	0.000269	0.00373	CcSEcCtD
Flurazepam—GABRA2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000269	0.00783	CbGpPWpGaD
Flurazepam—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000268	0.00373	CcSEcCtD
Flurazepam—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000268	0.00373	CcSEcCtD
Flurazepam—GABRB3—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000267	0.00778	CbGpPWpGaD
Flurazepam—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000265	0.00368	CcSEcCtD
Flurazepam—Asthenia—Betamethasone—ankylosing spondylitis	0.000265	0.00368	CcSEcCtD
Flurazepam—Asthenia—Dexamethasone—ankylosing spondylitis	0.000265	0.00368	CcSEcCtD
Flurazepam—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000263	0.00365	CcSEcCtD
Flurazepam—Nausea—Prednisolone—ankylosing spondylitis	0.000262	0.00365	CcSEcCtD
Flurazepam—GABRG2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000262	0.00764	CbGpPWpGaD
Flurazepam—Pruritus—Dexamethasone—ankylosing spondylitis	0.000261	0.00362	CcSEcCtD
Flurazepam—Pruritus—Betamethasone—ankylosing spondylitis	0.000261	0.00362	CcSEcCtD
Flurazepam—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000259	0.0036	CcSEcCtD
Flurazepam—Vomiting—Triamcinolone—ankylosing spondylitis	0.000258	0.00359	CcSEcCtD
Flurazepam—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000258	0.00358	CcSEcCtD
Flurazepam—Rash—Triamcinolone—ankylosing spondylitis	0.000256	0.00356	CcSEcCtD
Flurazepam—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000256	0.00356	CcSEcCtD
Flurazepam—Anorexia—Methotrexate—ankylosing spondylitis	0.000256	0.00355	CcSEcCtD
Flurazepam—Rash—Methylprednisolone—ankylosing spondylitis	0.000256	0.00355	CcSEcCtD
Flurazepam—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000255	0.00355	CcSEcCtD
Flurazepam—Headache—Triamcinolone—ankylosing spondylitis	0.000255	0.00354	CcSEcCtD
Flurazepam—Headache—Methylprednisolone—ankylosing spondylitis	0.000254	0.00353	CcSEcCtD
Flurazepam—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000252	0.00351	CcSEcCtD
Flurazepam—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000252	0.00351	CcSEcCtD
Flurazepam—Hypotension—Methotrexate—ankylosing spondylitis	0.000251	0.00348	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000245	0.0034	CcSEcCtD
Flurazepam—Dizziness—Betamethasone—ankylosing spondylitis	0.000244	0.00339	CcSEcCtD
Flurazepam—Dizziness—Dexamethasone—ankylosing spondylitis	0.000244	0.00339	CcSEcCtD
Flurazepam—Nausea—Triamcinolone—ankylosing spondylitis	0.000241	0.00335	CcSEcCtD
Flurazepam—Nausea—Methylprednisolone—ankylosing spondylitis	0.000241	0.00335	CcSEcCtD
Flurazepam—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000239	0.00332	CcSEcCtD
Flurazepam—Somnolence—Methotrexate—ankylosing spondylitis	0.000239	0.00332	CcSEcCtD
Flurazepam—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000236	0.00328	CcSEcCtD
Flurazepam—Vomiting—Dexamethasone—ankylosing spondylitis	0.000234	0.00326	CcSEcCtD
Flurazepam—Vomiting—Betamethasone—ankylosing spondylitis	0.000234	0.00326	CcSEcCtD
Flurazepam—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000233	0.00324	CcSEcCtD
Flurazepam—Rash—Dexamethasone—ankylosing spondylitis	0.000232	0.00323	CcSEcCtD
Flurazepam—Rash—Betamethasone—ankylosing spondylitis	0.000232	0.00323	CcSEcCtD
Flurazepam—Dermatitis—Betamethasone—ankylosing spondylitis	0.000232	0.00323	CcSEcCtD
Flurazepam—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000232	0.00323	CcSEcCtD
Flurazepam—Headache—Betamethasone—ankylosing spondylitis	0.000231	0.00321	CcSEcCtD
Flurazepam—Headache—Dexamethasone—ankylosing spondylitis	0.000231	0.00321	CcSEcCtD
Flurazepam—Asthenia—Prednisone—ankylosing spondylitis	0.00023	0.0032	CcSEcCtD
Flurazepam—GABRA1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000229	0.00667	CbGpPWpGaD
Flurazepam—Pruritus—Prednisone—ankylosing spondylitis	0.000227	0.00316	CcSEcCtD
Flurazepam—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000221	0.00307	CcSEcCtD
Flurazepam—Diarrhoea—Prednisone—ankylosing spondylitis	0.00022	0.00305	CcSEcCtD
Flurazepam—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000219	0.00305	CcSEcCtD
Flurazepam—Nausea—Betamethasone—ankylosing spondylitis	0.000219	0.00304	CcSEcCtD
Flurazepam—Nausea—Dexamethasone—ankylosing spondylitis	0.000219	0.00304	CcSEcCtD
Flurazepam—Dizziness—Prednisone—ankylosing spondylitis	0.000212	0.00295	CcSEcCtD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00021	0.00613	CbGpPWpGaD
Flurazepam—Vomiting—Prednisone—ankylosing spondylitis	0.000204	0.00284	CcSEcCtD
Flurazepam—Rash—Prednisone—ankylosing spondylitis	0.000202	0.00281	CcSEcCtD
Flurazepam—Dermatitis—Prednisone—ankylosing spondylitis	0.000202	0.00281	CcSEcCtD
Flurazepam—Headache—Prednisone—ankylosing spondylitis	0.000201	0.0028	CcSEcCtD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—IL1RN—ankylosing spondylitis	0.000194	0.00566	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—HLA-C—ankylosing spondylitis	0.000193	0.00564	CbGpPWpGaD
Flurazepam—Asthenia—Methotrexate—ankylosing spondylitis	0.000193	0.00268	CcSEcCtD
Flurazepam—Nausea—Prednisone—ankylosing spondylitis	0.000191	0.00265	CcSEcCtD
Flurazepam—Pruritus—Methotrexate—ankylosing spondylitis	0.00019	0.00264	CcSEcCtD
Flurazepam—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000184	0.00255	CcSEcCtD
Flurazepam—Dizziness—Methotrexate—ankylosing spondylitis	0.000177	0.00247	CcSEcCtD
Flurazepam—ABCB1—Allograft Rejection—IL17A—ankylosing spondylitis	0.000177	0.00515	CbGpPWpGaD
Flurazepam—Vomiting—Methotrexate—ankylosing spondylitis	0.000171	0.00237	CcSEcCtD
Flurazepam—Rash—Methotrexate—ankylosing spondylitis	0.000169	0.00235	CcSEcCtD
Flurazepam—Dermatitis—Methotrexate—ankylosing spondylitis	0.000169	0.00235	CcSEcCtD
Flurazepam—Headache—Methotrexate—ankylosing spondylitis	0.000168	0.00234	CcSEcCtD
Flurazepam—ABCB1—Allograft Rejection—IL12B—ankylosing spondylitis	0.000164	0.00479	CbGpPWpGaD
Flurazepam—Nausea—Methotrexate—ankylosing spondylitis	0.000159	0.00222	CcSEcCtD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—IL1A—ankylosing spondylitis	0.00014	0.00408	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—IL10—ankylosing spondylitis	0.000139	0.00405	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—IL1A—ankylosing spondylitis	0.000121	0.00352	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—CD40LG—ankylosing spondylitis	0.00012	0.0035	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—IL10—ankylosing spondylitis	0.00012	0.0035	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000115	0.00335	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—HLA-B—ankylosing spondylitis	0.000114	0.00333	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—HLA-A—ankylosing spondylitis	0.000106	0.00309	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—TNF—ankylosing spondylitis	5.29e-05	0.00154	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—TNF—ankylosing spondylitis	4.58e-05	0.00133	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—B3GNT2—ankylosing spondylitis	4.4e-05	0.00128	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—B3GNT2—ankylosing spondylitis	4.04e-05	0.00118	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—B3GNT2—ankylosing spondylitis	3.19e-05	0.00093	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—B3GNT2—ankylosing spondylitis	2.4e-05	0.0007	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	2.26e-05	0.000658	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—B3GNT2—ankylosing spondylitis	1.48e-05	0.000431	CbGpPWpGaD
